STK25 and metabolic dysfunction-associated steatohepatitis: In a recent study, Yeshwant Kurhe [28] found the depletion of STK25 could suppressed liver tumor growth and hinders the development of NASH-related HCC, through STAT3, ERK1/2, and p38 signaling pathway.